Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults
03:20pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Novavax (NVAX) gets authorization from the European Union to use its COVID-19 vaccine as a booster dose in adults.
Strength Seen in Galapagos NV (GLPG): Can Its 8% Jump Turn into More Strength?
02:21pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Galapagos NV (GLPG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Moderna, Inc. (MRNA) Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
02:16pm, Tuesday, 13'th Sep 2022
Moderna, Inc. (NASDAQ:MRNA ) Morgan Stanley 20th Annual Global Healthcare Conference September 13, 2022 10:00 AM ET Company Participants Stephen Hoge - President Conference Call Participants Matthew H
Got $1,000? 3 Stocks to Buy and Hold Until Retirement
10:56am, Tuesday, 13'th Sep 2022 The Motley Fool
These three stocks can help supercharge your retirement savings with reliability and above-average returns.
U.S. COVID cases continue to decline, as Minnesota nurses stage 3-day walkout over pay and understaffing
10:09am, Tuesday, 13'th Sep 2022 MarketWatch
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the true tally is likely higher given how many people are testing at home, where the data
1 Picture That Sums Up Moderna's Biggest Problem
09:55am, Tuesday, 13'th Sep 2022 The Motley Fool
Two trends appear to be working against Moderna right now.
This 1 Number Could Completely Change Your Opinion of Moderna
10:30am, Monday, 12'th Sep 2022 The Motley Fool
Moderna's recent prediction should lift one of investors' biggest fears.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Sector ETF report for RYH
Moderna says Japan regulator has approved partial change to NDA for its omicron-targeting COVID booster
07:14am, Monday, 12'th Sep 2022
Moderna Inc. MRNA, +0.71% said Monday the Japanese regulator has approved a partial change to its new drug application for its omicron-targeting COVID booster, MRNA-1273.214. The approval from the Min
This 1 Number Could Completely Change Your Opinion of Moderna
06:30am, Monday, 12'th Sep 2022
Moderna's recent prediction should lift one of investors' biggest fears.
Can nasal vaccines help prevent COVID-19 infections—or transmission?
03:00pm, Saturday, 10'th Sep 2022 MarketWatch
"The nasal vaccine is the best way to stop transmission or block it to the hilt,” says Dr. Eric Topol.
Is It Too Late to Buy Moderna Stock?
10:55am, Saturday, 10'th Sep 2022 The Motley Fool
The answer may depend on your investment horizon.
Is It Too Late to Buy Moderna Stock?
06:55am, Saturday, 10'th Sep 2022
The answer may depend on your investment horizon.
Moderna (MRNA) Gains But Lags Market: What You Should Know
09:45pm, Friday, 09'th Sep 2022 Zacks Investment Research
Moderna (MRNA) closed the most recent trading day at $142.33, moving +0.74% from the previous trading session.
Stock Market News for Sep 9, 2022
01:33pm, Friday, 09'th Sep 2022 Zacks Investment Research
Wall Street closed higher on Thursday, led by a rally in finance and healthcare stocks.
